Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1111

1.

Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.

Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM.

J Clin Psychiatry. 2000 Apr;61(4):276-81.

PMID:
10830148
2.
3.

Prevalence of sexual dysfunction among newer antidepressants.

Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RM, Jamerson BD, Metz A.

J Clin Psychiatry. 2002 Apr;63(4):357-66.

PMID:
12000211
5.

Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.

Landén M, Högberg P, Thase ME.

J Clin Psychiatry. 2005 Jan;66(1):100-6.

PMID:
15669895
6.
8.

Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.

Ferguson JM, Shrivastava RK, Stahl SM, Hartford JT, Borian F, Ieni J, McQuade RD, Jody D.

J Clin Psychiatry. 2001 Jan;62(1):24-9.

PMID:
11235924
9.

Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.

Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC.

J Clin Psychiatry. 2001 Mar;62(3):185-90.

PMID:
11305705
10.

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

Montejo-González AL, Llorca G, Izquierdo JA, Ledesma A, Bousoño M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De la Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E.

J Sex Marital Ther. 1997 Fall;23(3):176-94. Review.

PMID:
9292833
11.

A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.

Croft H, Settle E Jr, Houser T, Batey SR, Donahue RM, Ascher JA.

Clin Ther. 1999 Apr;21(4):643-58.

PMID:
10363731
12.

[Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients].

Montejo AI, Llorca G, Izquierdo JA, Ledesma A, Bousoño M, Calcedo A, Carrasco JL, Daniel E, de Dios A, de la Gándara J, Derecho J, Franco M, Gómez MJ, Macías JA, Martín T, Pérez V, Sánchez JM, Sánchez S, Vicens E.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1996 Nov-Dec;24(6):311-21. Spanish.

PMID:
9054202
13.

Burden of phase-specific sexual dysfunction with SSRIs.

Clayton A, Keller A, McGarvey EL.

J Affect Disord. 2006 Mar;91(1):27-32.

PMID:
16430968
15.

Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.

Fava M, Judge R, Hoog SL, Nilsson ME, Koke SC.

J Clin Psychiatry. 2000 Nov;61(11):863-7.

PMID:
11105740
17.

Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.

Modell JG, Katholi CR, Modell JD, DePalma RL.

Clin Pharmacol Ther. 1997 Apr;61(4):476-87.

PMID:
9129565
18.

Moclobemide: therapeutic use and clinical studies.

Bonnet U.

CNS Drug Rev. 2003 Spring;9(1):97-140. Review.

19.

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.

J Affect Disord. 2000 Aug;59(2):119-26.

PMID:
10837880
20.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239

Supplemental Content

Support Center